B
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- 8-K206.8 KBBellerophon Therapeutics, Inc.Mar 4, 5:25 PM ET·0001104659-24-030552
- SC 13G/A60.3 KBBellerophon Therapeutics, Inc.Feb 14, 4:50 PM ET·0001193125-24-036453
- SC 13G/A81.6 KBBellerophon Therapeutics, Inc.Feb 14, 4:00 PM ET·0001214659-24-002862
- 8-K276.8 KBBellerophon Therapeutics, Inc.Jan 30, 9:29 AM ET·0001104659-24-007999
- SC 13G115.3 KBBellerophon Therapeutics, Inc.Jan 26, 10:46 AM ET·0001013594-24-000074
- 8-K204.4 KBBellerophon Therapeutics, Inc.Jan 22, 3:21 PM ET·0001104659-24-005554
- 8-K206.2 KBBellerophon Therapeutics, Inc.Jan 10, 4:05 PM ET·0001104659-24-002968
- 8-K199.9 KBBellerophon Therapeutics, Inc.Nov 21, 4:05 PM ET·0001104659-23-120348
- 8-K202.4 KBBellerophon Therapeutics, Inc.Aug 7, 4:05 PM ET·0001104659-23-088330
- 8-K195.7 KBBellerophon Therapeutics, Inc.Jul 24, 4:10 PM ET·0001104659-23-083433
Insiders
10- Amin NaseemDirector
- Bruder Scott PDirector
- Cloyd Mary AnnDirector
- Dekker MartinVP OF ENGINEERING & MANUFACTUR
- Fernandes PeterCHIEF EXECUTIVE OFFICER
- Holt Matthew S.Director, 10% Owner
- Kim BobaeVP Reg. Affairs & Quality
- KLINSKY STEVEN B10% Owner
- Laccona NicholasFINANCIAL OFFICER, (PFO & PAO)
- New Mountain Capital, L.L.C.10% Owner
Tickers
No tickers on record
Addresses
business
184 LIBERTY CORNER ROAD, SUITE 302
WARREN, NJ, 07059
mailing
184 LIBERTY CORNER ROAD, SUITE 302
WARREN, NJ, 07059
Former Names
- Bellerophon Therapeutics LLC2015-02-13